Antibiotics and antivirals
These companies develop drugs that fight bacterial, fungal and viral infections, including HIV and hepatitis.
+17.1%
over 3 months · S&P 500 −2.1%
Key indicators
Health
45 / 100
Fragile
Solid
Price
P/E 6
Cheap
Expensive
Up over 1 year
3 of 15
Volatility
64%
Calm
Choppy
Health and price: against the other tags.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
The 15 companies
GILD
+21.7%
Size: weight in the tag. Color: move over the period.
See all companies
See all companies
G
Gilead Sciences
GILD
86.9%
+21.7%
I
Insmed
INSM
11.1%
−5.6%
V
Vir Biotechnology
VIR
0.8%
+6.1%
I
Innoviva
INVA
0.6%
−9.2%
A
Assembly Biosciences
ASMB
0.2%
−29.6%
C
CorMedix
CRMD
0.2%
−39.2%
E
Enanta Pharmaceuticals
ENTA
0.1%
−14.3%
E
Emergent Biosolutions
EBS
0.1%
+28.7%
I
Invivyd
IVVD
<0.1%
−21.4%
S
SCYNEXIS
SCYX
<0.1%
−36.9%
A
Aligos Therapeutics
ALGS
<0.1%
−68.1%
A
AIM ImmunoTech
AIM
<0.1%
−40.9%
A
Acurx Pharmaceuticals
ACXP
<0.1%
−41.8%
A
Arbutus Biopharma
ABUS
−13.2%
G
GSK
GSK
+0.3%